公司資料
Tyra Biosciences 股價、新聞與催化劑
- 股票代碼:
- TYRA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
26.05 USD (+1.40%)
收盤價
最後更新: 2026年8月21日
1.7B USD
市值
股價為何變動
As of Aug 21, 2026, TYRA closed up 1.40% at $26.05. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Tyra Biosciences is a precision-oncology company focused on FGFR and related kinase biology. The company is trying to build a targeted-therapy franchise around genetically defined cancers.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Tyra sits in specialty oncology biotechnology.
商業模式特徵
The company depends on clinical proof, molecule selectivity, and the possibility of creating a differentiated kinase platform.
生技產業定位
Tyra is a high-beta oncology name whose valuation is highly sensitive to early clinical data.
未來催化劑
- Tyra Biosciences's catalyst is TYRA-300, with FGFR3-driven bladder-cancer data and related FGFR updates likely to matter most. The market will care about whether the precision-oncology story stays differentiated.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。